ICSC 0119 - CAPTAFOL

« back to the search result list

CAPTAFOL	ICSC: 0119 (November 2009)
N-(1,1,2,2-Tetrachloroethylthio)cyclohex-4-ene-1,2-dicarboximide 3a,4,7,7a-Tetrahydro-N-(1,1,2,2-tetrachloroethanesulphenyl)phthalimide

CAS #: 2425-06-1

EC Number: 219-363-3

	ACUTE HAZARDS	PREVENTION	FIRE FIGHTING
FIRE & EXPLOSION	Combustible. Liquid formulations containing organic solvents may be flammable. Gives off irritating or toxic fumes (or gases) in a fire.	NO open flames.	Use water spray, foam, powder, carbon dioxide.

AVOID ALL CONTACT! IN ALL CASES CONSULT A DOCTOR!
	SYMPTOMS	PREVENTION	FIRST AID
Inhalation	Cough. Sore throat. Wheezing. Shortness of breath.	Use ventilation (not if powder), local exhaust or breathing protection.	Fresh air, rest. Refer for medical attention.
Skin	MAY BE ABSORBED! Redness. Rash. Blisters.	Protective gloves. Protective clothing.	Remove contaminated clothes. Rinse and then wash skin with water and soap. Refer for medical attention .
Eyes	Redness. Pain. Itching.	Wear face shield or eye protection in combination with breathing protection.	Rinse with plenty of water (remove contact lenses if easily possible). Refer for medical attention.
Ingestion	Burning sensation. Abdominal pain.	Do not eat, drink, or smoke during work. Wash hands before eating.	Rinse mouth. Refer for medical attention .

SPILLAGE DISPOSAL	CLASSIFICATION & LABELLING
Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Do NOT let this chemical enter the environment. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting. Carefully collect remainder. Then store and dispose of according to local regulations.	According to UN GHS Criteria DANGER Causes skin and eye irritation May cause allergic or asthmatic symptoms or breathing difficulties if inhaled May cause an allergic skin reaction May cause cancer May cause respiratory irritation Very toxic to aquatic life Transportation UN Classification
STORAGE
Provision to contain effluent from fire extinguishing. Separated from strong bases and food and feedstuffs. Store in an area without drain or sewer access.
PACKAGING
Do not transport with food and feedstuffs.

CAPTAFOL

ICSC: 0119

PHYSICAL & CHEMICAL INFORMATION
Physical State; Appearance COLOURLESS CRYSTALLINE POWDER. Physical dangers No data. Chemical dangers Decomposes on heating. This produces toxic and corrosive fumes including hydrogen chloride (see ICSC 0163), nitrogen oxides and sulfur oxides. Attacks metals.	Formula: C₁₀H₉Cl₄NO₂S Molecular mass: 349.1 Melting point: 160-161°C Solubility in water: none Relative vapour density (air = 1): 12 Relative density of the vapour/air-mixture at 20°C (air = 1): 1.00 Octanol/water partition coefficient as log Pow: 3.8

PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
COLOURLESS CRYSTALLINE POWDER.

Physical dangers
No data.

Chemical dangers
Decomposes on heating. This produces toxic and corrosive fumes including hydrogen chloride (see ICSC 0163), nitrogen oxides and sulfur oxides. Attacks metals.

Formula: C₁₀H₉Cl₄NO₂S
Molecular mass: 349.1
Melting point: 160-161°C
Solubility in water: none
Relative vapour density (air = 1): 12
Relative density of the vapour/air-mixture at 20°C (air = 1): 1.00
Octanol/water partition coefficient as log Pow: 3.8

EXPOSURE & HEALTH EFFECTS
Routes of exposure The substance can be absorbed into the body by ingestion. Effects of short-term exposure The substance is irritating to the eyes, skin and respiratory tract.	Inhalation risk A harmful concentration of airborne particles can be reached quickly when dispersed. Effects of long-term or repeated exposure Repeated or prolonged contact with skin may cause dermatitis. Repeated or prolonged contact may cause skin sensitization and allergic conjunctivities. Repeated or prolonged inhalation may cause asthma. This substance is probably carcinogenic to humans.

EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by ingestion.

Effects of short-term exposure
The substance is irritating to the eyes, skin and respiratory tract.

Inhalation risk
A harmful concentration of airborne particles can be reached quickly when dispersed.

Effects of long-term or repeated exposure
Repeated or prolonged contact with skin may cause dermatitis. Repeated or prolonged contact may cause skin sensitization and allergic conjunctivities. Repeated or prolonged inhalation may cause asthma. This substance is probably carcinogenic to humans.

OCCUPATIONAL EXPOSURE LIMITS
TLV: 0.1 mg/m³, as TWA; (skin); (SEN); A3 (confirmed animal carcinogen with unknown relevance to humans)

ENVIRONMENT
The substance is very toxic to aquatic organisms. This substance does enter the environment under normal use. Great care, however, should be taken to avoid any additional release, for example through inappropriate disposal.

NOTES
Depending on the degree of exposure, periodic medical examination is suggested. The symptoms of asthma often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential. Anyone who has shown symptoms of asthma due to this substance should avoid all further contact. Carrier solvents used in commercial formulations may change physical and toxicological properties. Do NOT take working clothes home.

NOTES

Depending on the degree of exposure, periodic medical examination is suggested.
The symptoms of asthma often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential.
Anyone who has shown symptoms of asthma due to this substance should avoid all further contact.
Carrier solvents used in commercial formulations may change physical and toxicological properties.
Do NOT take working clothes home.

ADDITIONAL INFORMATION

EC Classification
Symbol: T, N; R: 45-43-50/53; S: 53-45-60-61

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.